TITLE:
YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

CONDITION:
Prostate Cancer

INTERVENTION:
YM598

SUMMARY:

      The purpose of this study is to determine the optimal dosage of YM598 for slowing down
      disease progression in patients with rising PSA after initial therapy for localized prostate
      cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: Male
Age: 18 Years to N/A
Criteria:
NONE
